Vivoryon Therapeutics N.V.
Amsterdam Stock Exchange:VVY.AS
Sector
Industries
Location
Market Cap
USD 44.41 M
Share Price
USD 1.70
Avg Daily Volume
48,734
Change (1 day)
0.51%
Change (1 year)
-31.70%
Change (YTD)
-17.67%
Vivoryon Therapeutics N.V. EBITDA for the year ending December 31, 2024: USD -21.06 M
Vivoryon Therapeutics N.V. EBITDA is USD -21.06 M for the year ending December 31, 2024. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Vivoryon Therapeutics N.V. EBITDA for the year ending December 31, 2022 was USD -30.14 M, a 120.02% change year over year.
-
Vivoryon Therapeutics N.V. EBITDA for the year ending December 31, 2021 was USD -13.70 M, a -31.37% change year over year.
-
Vivoryon Therapeutics N.V. EBITDA for the year ending December 31, 2020 was USD -19.96 M, a 133.22% change year over year.
StockViz
Competitors
Eli Lilly and Company
USD 695.33
LLY
-16.35
-2.30%
AbbVie Inc.
USD 207.55
ABBV
-3.05
-1.45%
Roche Holding AG
USD 337.44
RO.SW
-3.52
-1.03%
Novo Nordisk A/S
USD 57.04
NOVO-B.CO
+0.05
0.10%
Novartis AG
USD 125.60
NOVN.SW
-1.46
-1.15%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Merck & Co., Inc.
USD 85.31
MRK
-2.06
-2.36%
Thermo Fisher Scientific Inc.
USD 490.75
TMO
-9.24
-1.85%
Amgen Inc.
USD 288.47
AMGN
-5.25
-1.79%
Pfizer Inc.
USD 25.14
PFE
-0.74
-2.86%
Gilead Sciences, Inc.
USD 114.15
GILD
-0.62
-0.54%
Sanofi
USD 100.24
SAN.PA
-2.14
-2.09%
Vertex Pharmaceuticals Incorporated
USD 388.94
VRTX
-6.18
-1.56%
Bristol-Myers Squibb Company
USD 47.14
BMY
-0.78
-1.63%
Chugai Pharmaceutical Co., Ltd.
USD 41.12
4519.T
-0.91
-2.16%
Key Data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Competitors
Eli Lilly and Company
USD 695.33
LLY
-16.35
-2.30%
AbbVie Inc.
USD 207.55
ABBV
-3.05
-1.45%
Roche Holding AG
USD 337.44
RO.SW
-3.52
-1.03%
Novo Nordisk A/S
USD 57.04
NOVO-B.CO
+0.05
0.10%
Novartis AG
USD 125.60
NOVN.SW
-1.46
-1.15%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Merck & Co., Inc.
USD 85.31
MRK
-2.06
-2.36%
Thermo Fisher Scientific Inc.
USD 490.75
TMO
-9.24
-1.85%
Amgen Inc.
USD 288.47
AMGN
-5.25
-1.79%
Pfizer Inc.
USD 25.14
PFE
-0.74
-2.86%
Gilead Sciences, Inc.
USD 114.15
GILD
-0.62
-0.54%
Sanofi
USD 100.24
SAN.PA
-2.14
-2.09%
Vertex Pharmaceuticals Incorporated
USD 388.94
VRTX
-6.18
-1.56%
Bristol-Myers Squibb Company
USD 47.14
BMY
-0.78
-1.63%
Chugai Pharmaceutical Co., Ltd.
USD 41.12
4519.T
-0.91
-2.16%